Oncology
News
Darbepoetin Worsens 5-Year Survival in Head and Neck Cancer
Major Finding: The addition of darbepoetin alfa to accelerated radiotherapy was associated with significantly worse locoregional tumor control (50...
News
FDA Reviewing Actos's Safety
News
Cancers of Unknown Primary: A Neglected Disease Attracts Attention
News
Toxic Erythema of Chemotherapy By Any Other Name
News
Initial Therapy Response Refines Risk Stratification for Thyroid Cancer
News
Pre-Op Contact Irradiation Plus EBRT Allows Rectal Sphincter Preservation
Major Finding: Although no patients who had EBRT before surgery were able to keep their rectum, 20% of those who had additional CXRT were able to...
News
Low-Dose Radioiodine as Effective as Higher Doses in Thyroid Remnant Ablation
Major Finding: Ablation rates approached 95%, whether patients were treated with 1.1 GBq of radioactive iodine or the standard 3.7 GBq dose.Data...
News
AHA: ‘Smokeless’ Tobacco Products Unsafe, Don’t Help Smokers Quit
Major Finding: Several meta-analyses indicate that smokeless tobacco use was associated with an increased risk of heart disease (relative risk 1....
News
Drug Combo May Prevent Glioblastoma Recurrence
News
Two Promising Drugs Identified for Basal Cell Carcinomas
Major Finding: Group A patients started with a median of 252 BCCs and had 127 at the most recent follow-up.Data Source: Phase II trial of 41...
News
Adjuvant Gemcitabine Comparable to Fluorouracil for Resected Pancreatic Cancer
Major Finding: Neither overall survival nor progression-free survival were significantly better with adjuvant gemcitabine, compared with standard...